Article Versions Notes

Back S, Knox B, Coakley C, Deltour N, Jacquot E, Raad H, Garry EM. Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc). Vaccines. 2024; 12(6):651. https://doi.org/10.3390/vaccines12060651

Back, Soowoo, Bethany Knox, Ciara Coakley, Nicolas Deltour, Emmanuelle Jacquot, Hanaya Raad, and Elizabeth M. Garry. 2024. "Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc)" Vaccines 12, no. 6: 651. https://doi.org/10.3390/vaccines12060651

Back, S., Knox, B., Coakley, C., Deltour, N., Jacquot, E., Raad, H., & Garry, E. M. (2024). Effectiveness and Safety of the MVA–BN Vaccine against Mpox in At-Risk Individuals in the United States (USMVAc). Vaccines, 12(6), 651. https://doi.org/10.3390/vaccines12060651